Efficacy of Azimilide for the Maintenance of Sinus Rhythm in Patients With Paroxysmal Atrial Fibrillation in the Presence and Absence of Structural Heart Disease

Azimilide hydrochloride (azimilide), an investigational antiarrhythmic drug, has shown variable efficacy in preventing atrial fibrillation (AF). This study was designed to assess its efficacy in maintaining sinus rhythm in patients with paroxysmal AF and heart disease. Patients with symptomatic paro...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2006-07, Vol.98 (2), p.215-218
Hauptverfasser:	Kerr, Charles R., Connolly, Stuart J., Kowey, Peter, Page, Richard L., Pritchett, Edward L.C., Ruda, Mikhail Y., Ruzyllo, Witold, Wilkinson, William E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Arrhythmia Agents - therapeutic use Atrial Fibrillation - complications Atrial Fibrillation - drug therapy Atrial Fibrillation - physiopathology Cardiac arrhythmia Cardiology Cardiovascular disease Clinical trials Confidence Intervals Coronary Disease - complications Coronary Disease - physiopathology Drug therapy Electrocardiography Female Heart Failure - complications Heart Failure - physiopathology Heart Rate - drug effects Heart Rate - physiology Humans Hydantoins Imidazolidines - therapeutic use Male Middle Aged Piperazines - therapeutic use Tachycardia, Paroxysmal - complications Tachycardia, Paroxysmal - drug therapy Tachycardia, Paroxysmal - physiopathology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!